KindlyMD (NASDAQ:NAKA) Given New $1.00 Price Target at B. Riley

KindlyMD (NASDAQ:NAKA) had its target price lowered by equities researchers at B. Riley from $2.00 to $1.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s target price indicates a potential upside of 102.55% from the company’s current price.

NAKA has been the subject of a number of other reports. Wall Street Zen raised shares of KindlyMD to a “sell” rating in a research note on Saturday, October 18th. Weiss Ratings restated a “sell (d-)” rating on shares of KindlyMD in a research report on Wednesday, October 8th. Zacks Research upgraded KindlyMD to a “hold” rating in a research report on Friday, October 17th. Finally, Maxim Group began coverage on KindlyMD in a research report on Wednesday, September 3rd. They set a “buy” rating and a $8.00 target price for the company. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, KindlyMD presently has a consensus rating of “Hold” and a consensus price target of $4.50.

KindlyMD Price Performance

Shares of NASDAQ:NAKA traded down $0.04 during trading on Thursday, reaching $0.49. The stock had a trading volume of 12,316,181 shares, compared to its average volume of 9,191,682. The company has a market cap of $217.15 million, a PE ratio of -0.57 and a beta of 30.71. KindlyMD has a 52 week low of $0.48 and a 52 week high of $34.77. The firm has a 50-day simple moving average of $1.04.

KindlyMD (NASDAQ:NAKA) last released its quarterly earnings results on Wednesday, November 19th. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%. The business had revenue of $0.39 million for the quarter, compared to analyst estimates of $0.40 million.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.